IBSA Institut Biochimique SA

Quick facts

Marketed products

• Diclofenac hydroxyethylpyrrolidine · Pain management, Rheumatology, Inflammation
  Diclofenac hydroxyethylpyrrolidine is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation.
• Proton pump inhibitor (PPI) · Gastroenterology
  Proton pump inhibitors block the hydrogen/potassium ATPase enzyme in gastric parietal cells, reducing gastric acid secretion.
• Tirosint®-SOL · Endocrinology
  Tirosint-SOL is a liquid formulation of levothyroxine that replaces deficient thyroid hormone to restore normal thyroid function.
• Urofollitrophin · Other

Phase 3 pipeline

• Diclofenac HPBCD · Pain management, Rheumatology, Inflammation
  Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain.
• FSH-IBSA · Reproductive Medicine / Fertility
  FSH-IBSA is a recombinant human follicle-stimulating hormone (FSH) that stimulates ovarian follicle development and estrogen production in women undergoing fertility treatment.
• hCG-IBSA
• hMG-IBSA · Reproductive Health
  Human menopausal gonadotropin is used to stimulate ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders.
• Placebo injectable solution
  This drug is a placebo, meaning it has no active therapeutic effect.
• Progesterone-IBSA Injectable Solution · Obstetrics/Gynecology
  Progesterone binds to progesterone receptors in the uterus and other reproductive tissues to maintain pregnancy and regulate the menstrual cycle.
• Progesterone Vaginal Gel with Applicator · Women's Health
  Progesterone acts as a steroid hormone that helps to maintain the pregnancy by preparing the uterus to implant a fertilized egg and supporting embryonic development.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• IBSA Institut Biochimique SA portfolio CI brief
• IBSA Institut Biochimique SA pipeline updates RSS